Journal
MUCOSAL IMMUNOLOGY
Volume 12, Issue 2, Pages 299-311Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/s41385-018-0130-4
Keywords
-
Categories
Funding
- Australian Research Council
- National Health and Medical Research Council (Australia)
- Faculty of Health, University of Newcastle
- MRC [MC_U105178805] Funding Source: UKRI
Ask authors/readers for more resources
Group 2 innate lymphoid cells (ILC2s) are a recently described subset of innate lymphocytes with important immune and homeostatic functions at multiple tissue sites, especially the lung. These cells expand locally after birth and during postnatal lung maturation and are present in the lung and other peripheral organs. They are modified by a variety of processes and mediate inflammatory responses to respiratory pathogens, inhaled allergens and noxious particles. Here, we review the emerging roles of ILC2s in pulmonary homeostasis and discuss recent and surprising advances in our understanding of how hormones, age, neurotransmitters, environmental challenges, and infection influence ILC2s. We also review how these responses may underpin the development, progression and severity of pulmonary inflammation and chronic lung diseases and highlight some of the remaining challenges for ILC2 biology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available